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Abstract
Due to the advent of allopathy and concomitant usage of the medicinal drugs with herbal
medicines, many herb drug interactions are increasingly reported in the scientific literature. In
this study, we have collected the scientific literature in the field of herb drug interactions
published between 2011 to 2019 and analyzed it for the scientometric trends to understand the
research direction in the last decade. We analyzed for the most prolific authors and their
affiliations, top ten countries, funding agencies that sponsored the most publications and
journals with most articles published in the field of herb drug interactions. We also identified
three top articles of the field, two out of which made it to the list of top articles (based on
citation count) of all time. We have identified upcoming research trend of network analysis and
systems biology approach in the broad field of herbal medicines and application into the field
of herb drug interactions. Our study demonstrated a dominant role of China and authors
working in Chinese institutions (research output measured through analysis of publications,
author contributions and grant fundings) in the field of herb drug interactions. As use of
allopathy and herbal medicines together is on the rise worldwide, we predict that herb drug
interactions will become an important concern in the future and precise regulatory guidelines
must be developed worldwide as soon as possible.
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Introduction
In today’s world, traditional medicines are used by over sixty percent of the world’s population.
Interestingly, a huge proportion of their consumers are present in developed countries even
though out of developing countries, China and India are still the leaders for traditional
medicinal systems. Nearly 40 percent of Chinese and approximately seventy percent of Indian
population uses traditional medicinal systems for treatment and about, 11,146 and 20,000
medicinal plants have been recorded with curative potential in China and India, respectively.
Currently, 8000 traditional Chinese herbal medicines and more than 10,000 Indian herbal
preparations (including Ayurvedic, Siddha, Unani, Homeopathic, Tibetan and folk
preparations) are available (1-3). Owing to the arrival of allopathy, people are using these
herbal treatments in conjunction with allopathic drugs resulting in herb-drug interactions. The
occurrence of herb-drug interactions is due to absence of awareness in general public as well
as limited reported scientific evidence available with the regulatory authorities. Many herb
drug interactions have recently become available in the literature (4-6). A retrospective
population-based study on adults that were given Ginkgo biloba alone or in combination with
anti-coagulant drugs displayed increased risk of haemorrhage in male patients aged 65 and
above (7). An Indian herb, Momordica charantia (popularly known as karela) has synergistic
interactions with four oral hypoglycaemic agents (Rosiglitazone, Metformin, Glibenclamide,
and Chlorpropamide) and administration of the herb and the drug together results in excessive
lowering of body blood glucose levels (8, 9).
Still, many herb-drug interactions are either under-reported or not yet known because they are
largely confused with drug side-effects. As a large portion of world population is using herbs
for treatment or symptomatic cure and is thus, at risk, of adverse effects due to reported or not
yet reported herb-drug interactions, this field requires considerable attention by the scientific
community. To assess if this is the case, we aimed to study the scientometrics about herb drug

interactions in the last nine years i.e. 2011-2019. We collected data from SCOPUS and
analyzed it for top authors, top funding agencies, top countries, top journals and top author
affiliations in the field of herb drug interactions. We also analyzed the top three articles of this
era to identify the upcoming research trend.
Methodology
Data acquisition and scientometry indicators assessment
We selected SCOPUS as a valid source for retrieval of data used for this scientometric analysis.
SCOPUS is the main international database for health sciences, and the terminology included
in its thesaurus can be used to search for published documents on specific aspects of a given
topic. A search with words ‘herb drug interactions’ as descriptor was performed for the years
2011-2019 to retrieve publications that contained these words in publications’ titles, keyword
lists, and abstracts (selection setting in the SCOPUS portal). Although it is possible that there
may be other terminologies, the search terms were kept broad to ensure that all the right
matches would be included. To refine the search results, document type articles or reviews was
selected and other document types such as book chapter, data paper, proceedings abstracts were
excluded. Once the search was complete, all the documents were selected and data for citation
information (author(s), document title, year, source title, volume, issue, pages, citation count,
source & document type), bibliographical information (affiliations, serial identifiers (e.g.
ISSN), PubMed ID, publisher, editor(s), language of original document, correspondence
address, abbreviated source title, DOI), abstract & keywords (abstract, author keywords, index
keywords), funding details (number, acronym, sponsor, funding text) was exported as CSV
files for subsequent analyses. The electronic search was performed in November, 2019 and
record of articles (original and review) with a total of 4,183 was retrieved. No restriction based
on language of articles was made although only a small percentage of total articles was non-

English (<8%). The above data was further assessed for identifying the most cited articles,
highest published researchers/authors, most influential funding agencies and countries.
Results
To assess the trend in the field of herb-drug interactions, we performed a search in SCOPUS
using the terms ‘herb drug interactions’ limited to original articles and review publication types
published between years 2011-2019. The search was performed to include the searched term
whenever it appeared in abstract, title of the publication and keywords. The data obtained was
assessed for indicators of scientometry such as trends in publications over the years, countries
with most prolific authors, funding agencies with most contributions in form of funding for
research and so forth.
Our assessment of the publications between years 2011-2019 demonstrated that the number of
publications has remained consistent throughout the years studied. No significant rise was
observed in the last 10 years with the majority of publications lying between 260 (in 2011) and
330 (in 2018) (Fig 1).
[Fig 1 here]
Although no trend could be identified in the number of publications in Fig 1, an assessment of
publications according to countries displayed China as the leader on herb drug interactions with
1208 publication, approximately half of the recorded publications (Fig 2). This is no surprise
as China is a world leader in traditional medicine (10). United States closely followed with 916
publications and, interestingly, authors from India, another hub for traditional medicinal
systems (Ayurveda, Siddha and Unani), have published comparatively smaller number of
publications (257) between 2011 and 2019. The variation in the total number of publications
between Fig 1 and Fig 2 arises from collaborations between authors from different countries
although only top 10 countries have been analyzed in Fig 2.
[Fig 2 here]

A bar graph analysis of sponsoring agencies funding the grants, associated with recorded
publications, demonstrated that six out of the top ten funding agencies were located in China
(Fig 3). This may explain the results obtained in Figure 2. NNSF or National Natural Science
Foundation of China, affiliated to China’s State Council, topped the list with 372 publications,
seven times as high as the closest competitor NBRP (973) or National Basic Research Program
of China (973 program). Although USA led the publications in the country wise analysis with
916 publications, only one USA funding agency i.e. NIH or National Institutes of Health made
it to the top ten. Furthermore, even if India came in third with 257 publications, none of the
Indian research funding agencies made it to the top 10 list.
[Fig 3 here]
A similar bar-graph analysis for top 10 journals displayed Journal of Ethnopharmacology
surpassed other journals with 176 publications closely followed by Phytotherapy Research with
104 publications and Evidence Based Complementary and Alternative Medicine with 78
publications during 2011-2019 (Fig 4).
[Fig 4 here]
Bar graph for top 10 author affiliations (Fig 5) showed Chinese Academy of Sciences (CAS
China; 118 publications) as the leader in the field of herb-drug interactions between 2011-2019,
closely followed by Chinese University of Hong Kong (CU Hong Kong; 106 publications) and
Ministry of Education China (ME China; 81 publications).
[Fig 5 here]
E. Ernst led the list of top 10 authors with 31 publications in 2011 to 2019-year range while M.
Huang (23), Y. C. Hou (22), S.F. Zhou (21) and J.A. Duan (20) published 20-23 articles in the
same time-period (Table 1).
[Table 1 here]

In addition, an analysis of the top three articles in our search identified three articles, published
during 2013-2014, as the most cited articles (Table 2). These articles were “Structure and
dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive
review”, “A review on therapeutic potential of Nigella sativa: A miracle herb” and “TCMSP:
A database of systems pharmacology for drug discovery from herbal medicines” with citation
counts of 445, 339 and 297 respectively. Interestingly, none of these articles could be attributed
to the identified top authors in table 1.
[Table 2 here]
Discussion
As a considerable number of people, even westerners, are turning towards herbal medicines,
herb-drug interactions are increasingly gaining public interest. As of now, testing of herb drug
interactions is not an essential part of allopathic drug development process and therefore, these
interactions are easily missed. China and India are important regions for local traditional
medicinal systems and the advent of allopathy has resulted in increased probability of herb
drug interactions in these countries. Perceiving the need for interaction testing, China have
been world leaders in this field as evident from the publication count and funding for research
as observed in our collected data. Almost half of the publications (1208) were authored or coauthored by Chinese authors (Fig 2). It was surprising that although India is a hub for traditional
medicine too (such as Ayurveda), Indian authors authored or co-authored only 257
publications. As our data is based on SCOPUS search, we cannot rule out the possibility of
Indian researchers publishing in non-SCOPUS indexed journals. In addition, India has local
journals, many of which are not SCOPUS indexed. We did observe a variation in the
publication count between Figure 1 and Figure 2 which could be based on collaborations
between authors from different nationalities. This would explain the publication count of 2124
for China (1208) and USA (916) and indicate huge number of China-USA collaborations in

the field of herb-drug interactions. The high amount of Chinese researchers-authored
publications also correlates with the six funding agencies being Chinese as shown in figure 3.
Interestingly, only one funding agency, NIH, has been involved in funding USA based research
in this field and none of the Indian funding agencies made it to the list of top ten funding
sponsoring agencies. This may indicate a regional bias for research area and possibility that
while China heavily invested in identifying possible drug interactions with herbs used in
traditional Chinese medicines and American scientists, therefore, heavily collaborated with
them, Indian funding agencies channelized their funds on other areas of biological sciences.
Journal of Ethnopharmacology, Phytotherapy Research and Evidence Based Complementary
and Alternative Medicine published the highest number of research and review articles on herb
drug interactions between 2011 and 2019 as shown in Figure 4. Majority of the journals in the
top ten are natural medicine-based journals. Although any herb drug interaction report is
equally important both for readers and scientific community working on herbal medicines as
well as allopathy, this may result in unequal distribution of scientific reporting. According to
our collected data, few allopathy-based journals publish reports of herb drug interactions. Our
data from Figure 5 confirmed the finding that most of the publications were co-authored by
Chinese researchers as majority of affiliations were located in China and displayed the highly
collaborative attitude of Chinese researchers in the field of herb drug interactions. Interestingly,
E. Ernst, an author working in United Kingdom and not working in China, topped the list of
authors with 31 publications (Table 1). He is affiliated with Department of Complementary
Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, Exeter,
United Kingdom and all his 31 publications were funded by National Center for
Complementary and Alternative Medicine (NCCAM), USA and National Health Service
(NHS), U.K. (data through assessment of author’s profile from scientific database online).
Also, four publications authored by E. Ernst made it to the top 20 publications of all-time list

(Suppl Table 1). Top three authors also include M. Huang, China (23) and Y.C. Hou, Taiwan
(22). Five Chinese authors (Table 1) made it to the top 10 list while no Indian authors made it
to the list. Other authors, S.F. Zhou, Hong kong (21), B.J Gurley, USA (19) and T.H Tsai,
France (19) were also included in the top authors list.
An analysis of top three articles published during 2011-2019, based on citation count, indicated
that novelty has gained importance in the last decade. It is surprising that although these articles
were published comparatively recently, two of the top articles of the assessed years made it to
the list of top 20 articles of all time (Suppl Table 1). Not surprisingly, All the top three articles
are review articles. Also, 14 articles in the top publication of all-time list are review articles
indicating that review articles are cited more frequently than research articles (Supple Table
1). Two of these articles, namely, “Structure and dynamics of molecular networks: a novel
paradigm of drug discovery: a comprehensive review” and “TCMSP: A database of systems
pharmacology for drug discovery from herbal medicines” utilized and merged upcoming
scientific areas such as molecular networks and database mapping. Both these articles set a
precedent in the broader field of biological sciences and demonstrated the application of online
databases and network analysis in herb drug interactions. All the three articles (Table 2) have
included the term herb drug interactions in that met are search criteria (see methodology section
for detailed search parameters).
The review article titled “Structure and dynamics of molecular networks: a novel paradigm of
drug discovery: a comprehensive review” published in 2013 in the Journal ‘Pharmacology &
Therapeutics’ is a comprehensive review on molecular networks and possible application in
drug discovery. The article has been cited by 445 publications till our search. The article
performed a comprehensive assessment of the analytical tools of network topology and
dynamics. The two basic strategies for network targeting i.e. central hit strategy and network
influence strategy have been described and their role in identification of single-target, edgetic,

multi-target and allonetwork drug target candidates have been discussed. This 190-page article
describes important tools to study and identify molecular networks and their role in diseases
and possible targeting in cancer and diabetes. Although this article is important for drug
discovery and development per se, it has acted as a breakthrough for herb-based drug
development too. Drug-drug interactions as a measure of network interactions with a direct
reference to online databases has been discussed. Interestingly, use of networks to assess herbdrug interactions has resulted through the networks or interaction partners that were identified
through this approach. Many interactions such as herb CYP450 interactions (11-13). Although
the term herb drug interactions has been vaguely mentioned in the articles that have cited this
review article, many articles are too broad to categorize under a specific category. However,
as this approach shows promise in identifying herb-drug or herb-CYP (effect on drug
metabolism) in the field, its role as a milestone cannot be disputed.
The article titled “TCMSP: A database of systems pharmacology for drug discovery from
herbal medicines” describes a free online platform that converges information of
pharmacochemistry, ADME properties, drug-likeness, drug targets, associate diseases and
interaction networks for traditional Chinese medicine. The database indirectly aims at widening
the understanding of mechanism of actions for Chinese herbal medicines and possible herb
targets inclusive drug interactions and provides tools for visualization at the network level.
This article has acted as a milestone for many research articles published on network
pharmacology of Chinese herbal medicines in later years (14-16). Network pharmacology has
been further explored for disease specific herbal treatments and targets such as in
neurodegenerative diseases (17, 18), hepatoma and hepatoprotective mechanisms (19-21),
vitiligo (22), cardiovascular diseases (19, 23), diabetes mellitus (24) and many more. Attempt
to identify new herbal drug candidates for cancer therapy (25) and explain herb combinations
in a concoction have also been performed (26). All the above approaches have thus identified

herb phytoconstituent targets which may be shared by allopathic drugs as well as herb effects
on the body’s metabolic enzymes such as CYP450s.
Review article titled “A review on therapeutic potential of Nigella sativa: A miracle herb”
published in 2013 also made it to top articles of all time with 339 citations during our analysis.
This article is a collaboration between Indian authors and authors working in the middle east.
Nigella sativa is a widely used medicinal plant especially in middle eastern and Indian
traditional systems. Its pharmacological properties have been explored as an anti-diabetic, anticancer, immunomodulator, analgesic, antimicrobial, anti-inflammatory, spasmolytic,
bronchodilator, hepatoprotective, renal protective, gastroprotective and anti-oxidant and the
review describes a detailed literature survey on Nigella sativa pharmacognostical
characteristics, chemical composition and pharmacological activities of the seeds of the plant.
In our understanding, the topic covered in this review is very broad and thus the chances of the
citation increase considerably. Therefore, the review has been extensively cited in research and
review articles that discuss the herb directly (27-30) or vaguely mention connected topics (3134). This review article has discussed the possible Herb drug interactions for Nigella sativa.
These publications demonstrate an open and collaborative attitude of research scientists
working the field of herb drug interactions and a paradigm shift to include new age methods in
science. Finally, our study demonstrates a dominant role of China (research output measured
through analysis of publications, author contributions and grant fundings). It is unfortunate that
a similar trend could not be observed for other countries invested in usage of traditional herbal
medicines resulting in a research gap in these medicinal systems.
Conclusion
In this scientometric study, we have identified China as the leader in the field of herb-drug
interactions with almost half of publication authored or co-authored by Chinese researchers in
SCOPUS indexed journals. Six Chinese researchers made it to the top ten prolific authors list

for the period of 2011 to 2019. We also found that China is leading in the funding provided to
researchers with six Chinese funding agencies listed in the top 10. Although important
traditional medicinal systems such as Ayurveda and Siddha are localized in India, the
publication count and absence of Indian authors and funding agencies in the top ten indicates
a regression on identification and implementation of information on herb drug interactions
locally. The same scenario is envisaged for other countries with prolific users of traditional
medicinal systems (e.g. Brazil). As use of allopathy and herbal medicines together is on the
rise worldwide, we predict that herb drug interactions will become an important concern in the
future and precise regulatory guidelines must be developed worldwide as soon as possible. Our
literature analysis proves a steady output of publications in the field although better research
output is observed for Chinese traditional medicines than other systems. A similar attitude must
be adopted by other countries that heavily bank on traditional medicines and herb drug
interaction testing should be made an important part of any drug development.
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Figure 1 2011-2019 trend in publications on herb drug interactions. SCOPUS search
on ‘herb drug interactions’ for original articles and review articles between 2011 to 2019
were plotted in to a bar-graph and assessed for possible trends in research.
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Figure 2 Trend in publication count for the top 10 countries. Bar graphs were prepared
for the identified top 10 countries leading the ‘herb drug interactions’ field in 2011-2019
time period.
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Figure 3 Bar graph analysis of top 10 funding agencies. Top 10 funding agencies that
financed the highest number of publications in the field of ‘herb drug interactions’ were
identified and plotted on a bar graph for the years 2011-2019. Full names of funding
agencies with abbreviations used in graph are given in the table.
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Figure 4 Top 10 Journals in the field of herb drug interactions during 2011-2019. Journals
were classified into top 10 journals on the basis of publication count and plotted in a bar graph.
Full journal names with abbreviations used in graph are given in the table.
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Figure 5 Top 10 Affiliations in the field of herb drug interactions during 2011-2019.
Author affiliations were ordered according to publication count and plotted in a bar graph. Full
affiliations with abbreviations used in graph are given in the table.

Table 1 Top 10 authors in the field of herb drug interactions during 2011-2019. Individual
author publications were counted and indexed into the table to produce a list of top 10 authors
in the research area during 2011-2019.
Author
name
Ernst, E.

Author affiliation and country

Department of Complementary Medicine, School of
Postgraduate Medicine and Health Sciences,
University of Exeter, Exeter, United Kingdom
Huang, M.
State Key Laboratory of Bioactive Substance and
Function of Natural Medicines, Institute of Materia
Medica, Chinese Academy of Medical Sciences /
Peking Union Medical College, Beijing 100050,
China.
Hou, Y.C.
Graduate Institute of Pharmaceutical Chemistry,
China Medical University, Taichung, 40402, Taiwan.
Yang, L.
Laboratory of Pharmaceutical Resource Discovery,
Dalian Institute of Chemical Physics, Chinese
Academy of Sciences, Dalian, China.
Zhou, S.F.
Discipline of Chinese Medicine, School of Health
Sciences, RMIT University, Victoria, Australia.
Duan, J.A.
Jiangsu Key Laboratory for High Technology
Research of TCM Formulae, Nanjing University of
Chinese Medicine, Nanjing 210046, China
Fang, Z.Z
Laboratory of Pharmaceutical Resource Discovery,
Dalian Institute of Chemical Physics, Chinese
Academy of Sciences, Dalian, China.
Gurley, B.J
Department of Pharmaceutical Sciences, University
of Arkansas for Medical Sciences, College of
Pharmacy, Little Rock, AR 72205, USA.
Tsai, T.H
Laboratoire de Toxicologie Cellulaire, EA 4267, IFR
133, UFR Pharmacie, Place Saint-Jacques, 25030
Besançon, France.
Yeung, J.H.K School of Biomedical Sciences, Faculty of Medicine,
The Chinese University of Hong Kong, Hong Kong,
China.

publication
count
31

23

22
22

21
20

19

19

19

19

Table 2 Top three publications during 2011-2019 based on the citation count as in Nov
2019 authors in the field of herb drug interactions. An extensive analysis of original
research and review articles during the time period was performed to identify the three
publications with the highest citation count.
Article
Structure and dynamics of molecular networks: a novel
paradigm of drug discovery: a comprehensive review.
Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R.
Pharmacol Ther. Jun;138(3):333-408.
A review on therapeutic potential of Nigella sativa: A miracle
herb. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK,
Siddique NA, Damanhouri ZA, Anwar F. Asian Pac J Trop
Biomed. 2013 May;3(5):337-52.
TCMSP: A database of systems pharmacology for drug
discovery from herbal medicines. Ru J, Li P, Wang J, Zhou W,
Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y,
Wang Y, Yang L. J Cheminform. 2014 Apr 16;6:13.

Year of
# Citations
publishing
2013
445

2013

339

2014

297

Table 3 Top 20 publications of all time based on the citation count as in Nov 2019 authors
in the field of herb drug interactions. Top research and review articles of all time based on
citation count on the day of the search with term ‘herb drug interactions’ were collected and
indexed in the table.
S.
Article
No.
1
Danshen: An overview of its chemistry,
pharmacology, pharmacokinetics, and clinical
use. Zhou L, Zuo Z, Chow MS. J Clin
Pharmacol. 2005 Dec;45(12):1345-59.
2
Herb-drug interactions. Fugh-Berman A. Lancet.
2000 Jan 8;355(9198):134-8.
3
Complementary/ alternative medicine use in a
comprehensive cancer center and the
implications for oncology. Richardson MA,
Sanders T, Palmer JL, Greisinger A, Singletary
SE. J Clin Oncol. 2000 Jul;18(13):2505-14.
4
Herbal medicines and perioperative care. AngLee MK, Moss J, Yuan CS. JAMA. 2001 Jul
11;286(2):208-16.
5
Herbal medicinals: Selected clinical
considerations focusing on known or potential
drug-herb interactions. Miller LG. Arch Intern
Med. 1998 Nov 9;158(20):2200-11.
6
Synergy and other interactions in
phytomedicines. Williamson EM.
Phytomedicine. 2001 Sep;8(5):401-9.
7
Interactions between herbal medicines and
prescribed drugs: A systematic review. Izzo AA,
Ernst E. Drugs. 2001;61(15):2163-75.
8
Pharmacokinetic interaction of digoxin with an
herbal extract from St John’s wort (Hypericum
perforatum). Johne A, Brockmöller J, Bauer S,
Maurer A, Langheinrich M, Roots I. Clin
Pharmacol Ther. 1999 Oct;66(4):338-45.
9
Free-radical scavenging action of medicinal
herbs from Ghana: Thonningia sanguinea on
experimentally-induced liver injuries. Gyamfi
MA, Yonamine M, Aniya Y. Gen Pharmacol.
1999 Jun;32(6):661-7.
10 Harmless herbs? A review of the recent
literature. Ernst E. Am J Med. 1998
Feb;104(2):170-8.
11 A genetic framework of the control of cell
division and differentiation in the root meristem.
Dello Ioio R, Nakamura K, Moubayidin L,
Perilli S, Taniguchi M, Morita MT, Aoyama T,

Article
type
Review

Year of
#
publishing Citations
2005
931

Review

2000

901

Research 2000

778

Review

2001

730

Review

1998

692

Review

2001

557

Review

2001

553

Research 1999

524

Research 1999

495

Review

1998

490

Research 2008

486

12

13

14

15

16
17

18

19

20

Costantino P, Sabatini S. Science. 2008 Nov
28;322(5906):1380-4
Herb-drug interactions: A literature review. Hu
Z, Yang X, Ho PC, Chan SY, Heng PW, Chan
E, Duan W, Koh HL, Zhou S. Drugs.
2005;65(9):1239-82.
Structure and dynamics of molecular
networks: a novel paradigm of drug
discovery: a comprehensive review.
Csermely P, Korcsmáros T, Kiss HJ, London
G, Nussinov R. Pharmacol Ther.
Jun;138(3):333-408.
The risk-benefit profile of commonly used
herbal therapies: Ginkgo, St. John’s wort,
ginseng, echinacea, saw palmetto, and kava.
Ernst E. Ann Intern Med. 2002 Jan 1;136(1):4253.
Interactions between herbal medicines and
prescribed drugs: an updated systematic review.
Izzo AA, Ernst E. Drugs. 2009;69(13):1777-98
Cardiovascular effects of Danshen. Cheng TO.
Int J Cardiol. 2007 Sep 14;121(1):9-22.
Herbal remedies in the United States: Potential
adverse interactions with anticancer agents.
Sparreboom A, Cox MC, Acharya MR, Figg
WD.
J Clin Oncol. 2004 Jun 15;22(12):2489-503.
A review on therapeutic potential of Nigella
sativa: A miracle herb. Ahmad A, Husain A,
Mujeeb M, Khan SA, Najmi AK, Siddique
NA, Damanhouri ZA, Anwar F. Asian Pac J
Trop Biomed. 2013 May;3(5):337-52.
Degradation of ginsenosides in humans after oral
administration. Tawab MA, Bahr U, Karas M,
Wurglics M, Schubert-Zsilavecz M. Drug Metab
Dispos. 2003 Aug;31(8):1065-71.
Investigation of the interaction between
Berberine and human serum albumin. Hu YJ,
Liu Y, Xiao XH. Biomacromolecules. 2009 Mar
9;10(3):517-21.

Review

2005

482

Review

2013

445

Review

2002

407

Review

2009

396

Review

2007

369

Review

2004

354

Review

2013

339

Research 2003

337

Research 2009

336

